INtegrated Colonoscopy Improvement Program in Italy
incipit
1 other identifier
observational
21,250
1 country
1
Brief Summary
The Italian Society of Digestive Endoscopy (SIED) and the Italian Association of Gastroenterologists and Hospital Digestive Endoscopists (AIGO) want to develop an effective training program for endoscopists to improve the quality of colonoscopies through careful evaluation of quality indicators and how they can be improved with an appropriate educational program. Primary objective of this study is to evaluate the variation of "Polyp Detection Rate (PDR) and Adenoma Detection Rate (ADR)" obtained by operators at high and low volume of colonoscopy before and after a training period. Secondary objectives are to compare high and low volume endoscopists' performance before and after training comparing by evaluation of withdrawal time; Number polyps / patient and Number adenomas / patient; the percentage and time of intubation of the cecum, ; patient's pain perception based on the Nurse Assessed Patient Comfort Score (NAPCOMS) scale. The study is structured as follow:
- A first phase when all endoscopists collect the results of 200 colonoscopies in an electronic Case Report Form (eCRF) is formed(maximum enrollment period 4 months).
- A second phase of training through an e-platform in which the endoscopists are offered with an online refresh reviewing the international standard parameters to perform a quality colonoscopy. Once the final training exam have been passed, the endoscopist will be able to access the third phase
- A third phase in which the endoscopists will collect prospectively the colonoscopies they perform in an eCRF (maximum enrollment period 4 months).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 29, 2018
CompletedStudy Start
First participant enrolled
August 29, 2018
CompletedFirst Posted
Study publicly available on registry
September 7, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedDecember 18, 2019
December 1, 2019
2.3 years
August 29, 2018
December 17, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Adenoma detection rate
to evaluate Adenoma Detection Rate obtained by operators at high and low volume of colonoscopy before and after a training period(ADR)"
9 months
Polyps detection rate
to evaluate the variation of "Polyp Detection Rate (PDR) obtained by operators at high and low volume of colonoscopy before and after a training period
9 months
Secondary Outcomes (6)
Withdrawal time
9 months
Number polyps / patient
9 months
Number adenomas / patient
9 months
percentage of intubation of the cecum
9 months
time of intubation of the cecum
9 months
- +1 more secondary outcomes
Interventions
endoscopists' performance outcome
Eligibility Criteria
Patient aged between 50 and 75 years old who present with abdominal symptoms suggestive for colonic patholgy or included in cancer screening program
You may qualify if:
- patients between 50 and 75 years old
- colonoscopy for cancer screening program, post polypectomy follow up, patients with abdominal symptoms suggestive for colonic pathology.
You may not qualify if:
- patients aged \< 50 or \> 75 yrs
- presence of alarm symptoms
- American Society of Anesthesiologists (ASA) Classification ≥ 3
- presence of colonic stenosis
- previous colonic resection
- Presence of diverticulitis
- history of Inflammatory Bowel Disease (IBD)
- History of polyposis syndrome
- Pregnancy or breastfeeding
- inability to provide informed consent
- Severe cardiovascular illness
- contraindication to undergo to sedation
- Anticoagulant therapy
- Melanosis coli
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pier Alberto Testoni
Milan, 20132, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
August 29, 2018
First Posted
September 7, 2018
Study Start
August 29, 2018
Primary Completion
December 1, 2020
Study Completion
December 1, 2021
Last Updated
December 18, 2019
Record last verified: 2019-12